Biocompatible lipid polymer cationic nanoparticles for antigen presentation

Biocompatible lipid polymer nanoparticles (NPs) previously used as antimicrobial agents are explored here as immuno-adjuvants. Poly (methyl methacrylate) (PMMA)/dioctadecyldimethylammonium bromide (DODAB)/poly (diallyldimethylammonium chloride) (PDDA) nanoparticles (NPs) were prepared by emulsion polymerization of methyl methacrylate (MMA) in the presence of DODAB and PDDA, with azobisisobutyronitrile (AIBN) as the initiator. NPs characterization after dialysis by dynamic light-scattering yielded 225 ± 2 nm hydrodynamic diameter (Dz), 73 ± 1 mV zeta-potential (ζ), and 0.10 ± 0.01 polydispersity (P). Ovalbumin (OVA) adsorption reduced ζ to 45 ± 2 mV. Balb/c mice immunized with NPs/OVA produced enhanced OVA-specific IgG1 and IgG2a, exhibited moderate delayed type hypersensitivity reaction, and enhanced cytokines production (IL-4, IL-10, IL-2, IFN-γ) by cultured spleen cells. There was no cytotoxicity against cultured macrophages and fibroblasts. Advantages of the PMMA/DODAB/PDDA NPs were high biocompatibility, zeta-potential, colloidal stability, and antigen adsorption. Both humoral and cellular antigen-specific immune responses were obtained.
humoral and cellular immune responses;  cationic lipid;  cationic polymer;  ovalbumin;  hybrid nanoparticles;  protein delivery;  vaccine adjuvants;  cationic nanoparticles toxicity

Document type
Pérez-Betancourt Y, Távora BCLF, Faquim Mauro EL, AMC-R. Biocompatible lipid polymer cationic nanoparticles for antigen presentation. Polymers.. 2021 Jan;13:185. doi:10.3390/polym13020185.
Appears in Collections:
Open Access

Files in This Item:
File Description SizeFormat Existing users please Login
10.3390polym13020185.pdf3.66 MBAdobe PDFEmbargoed until January 1, 2999    Request a copy
Show full item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.